(Q40151501)

18 September 2017

1 reference

title

Schizophrenia: some current neurochemical approaches (English)

1 reference

18 September 2017

Schizophrenia: Some Current Neurochemical Approaches (English)

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

4 October 2023

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

4 October 2023

author name string

R. Rodnight

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6345723

4 October 2023

language of work or name

English

0 references

publication date

1 July 1983

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1471-4159.1983.tb11809.x

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1471-4159.1983.tb11809.x

4 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Journal of Neurochemistry

4 October 2023

published in

1 reference

18 September 2017

volume

41

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

12-21

1 reference

Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

21 January 2018

Methylation Hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Altered states of consciousness induced by N,N-dimethyltryptamine (DMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Central dopamine turnover in schizophrenic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

The activities of brain dopamine-?-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Is schizophrenia an infectious disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Blood tryptophan metabolism in chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Brain catecholamines in schizophrenia -- a good case for noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Behavioural changes induced by N,N-dimethyl-tryptamine in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Plasma prolactin concentrations and psychopathology in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Increased dopamine-receptor sensitivity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Change in the characteristics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: Effects of buffer washing of membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Phenylethylamine in paranoid chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Cerebral ventricular size in twins discordant for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Neuroendocrine Effects of Apomorphine: Characterization of Response Patterns and Application to Schizophrenia Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Human platelet monoamine oxidase activity in health and disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Increased synthesis of striatal dopamine by N,N-dimethyltryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine or S-adenosylmethionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

The viral hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Possible virus in schizophrenia and some neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Neurochemical investigations of the interaction of N,N-dimethyltryptamine with the dopaminergic system in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism. Correlations with MMPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Ventricular enlargement in schizophrenia: definition and prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

Twin Studies and Substrate Differences in Platelet Monoamine Oxidase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11809.X

21 January 2018

Schizophrenia

3

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

A diagnostic pointer to adult metachromatic leucodystrophy

4 October 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Schizophrenia in a North Swedish geographical isolate, 1900-1977. Epidemiology, genetics and biochemistry

4 October 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

CSF GABA in psychotic disorders

4 October 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Biological homogeneity, symptom heterogeneity, and the diagnosis of schizophrenia

4 October 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia

4 October 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients

4 October 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

4 October 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration

4 October 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors

4 October 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

4 October 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Increased whole blood serotonin concentrations in chronic schizophrenic patients

4 October 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity

4 October 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Serum dopamine-beta-hydroxylase in schizophrenic patients

4 October 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

An endogenous inhibitor of indoleamine-N-methyltransferase in cerebrospinal fluid

4 October 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Factors Affecting Determination of Platelet Monoamine Oxidase Activity

4 October 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms

4 October 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

The Syndrome of Schizophrenia: Unresolved Questions and Opportunities for Research

4 October 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Gamma-Aminobutyric Acid (GABA) in the CSF of Schizophrenic Patients Before and After Neuroleptic Treatment

4 October 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Clinical course of adult metachromatic leukodystrophy presenting as schizophrenia. A report of two living cases in siblings

4 October 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

4 October 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

γ‐Aminobutyric Acid Concentration in Cerebrospinal Fluid in Schizophrenia

4 October 2023

63

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response

4 October 2023

66

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Schizophrenia: a new approach

4 October 2023

70

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Platelet Monoamine Oxidase Activity in Acute Schizophrenia: Relationship to Symptomatology and Neuroleptic Medication

4 October 2023

73

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Schizophrenia-like psychosis caused by a metabolic disorder

4 October 2023

75

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders

4 October 2023

88

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

The effect of pimozide on CSF norepinephrine in schizophrenia

4 October 2023

89

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients

4 October 2023

96

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

Improved selective ion monitoring mass-spectrometric assay for the determination of n,n-dimethyltryptamine in human blood utilizing capillary column gas chromatography

4 October 2023

98

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.1983.TB11809.X

4 October 2023

Identifiers

1 reference

18 September 2017

1 reference